aspirin has been researched along with thromboplastin in 76 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (28.95) | 18.7374 |
| 1990's | 16 (21.05) | 18.2507 |
| 2000's | 28 (36.84) | 29.6817 |
| 2010's | 9 (11.84) | 24.3611 |
| 2020's | 1 (1.32) | 2.80 |
| Authors | Studies |
|---|---|
| Hey, D; Schöndorf, TH | 1 |
| Glaves, D; Weiss, L | 1 |
| Gurewich, V; Hume, M; Kuriakose, TT; Nunn, T | 1 |
| Komp, DM | 1 |
| Mason, RG; Shinoda, BA; Zucker, WH | 1 |
| Olsen, JO; Osterud, B; Wilsgård, L | 1 |
| Balasch, J; Bosch, X; Cervera, R; Font, J; Ingelmo, M; López-Soto, A; Navarro, M; Pallarés, L | 1 |
| DeWind, SA; Herrmann, EC; Leach, RD; Slattery, CW | 1 |
| Broekman, MJ; Lorenzet, R; Marcus, AJ; Niemetz, J | 1 |
| Delvos, U; Janssen, B; Müller-Berghaus, G | 1 |
| Goto, K; Imamura, H; Nakanishi, M | 1 |
| Beys-Col, CD; Masure, R; Moriau, M; Noel, H; Rodhain, J | 1 |
| King, JB | 1 |
| de Gaetano, G; Vermylen, J; Verstraete, M | 2 |
| Hilgard, P; Hohage, R; Minne, H; Schmitt, W; Ziegler, R | 1 |
| Whaun, JM | 1 |
| Bleyer, WA; Breckenridge, RT | 1 |
| Weiner, M | 1 |
| O'Brien, JR | 1 |
| Chervenick, PA; Factor, A; Weiss, HJ; Zalusky, R | 1 |
| Bouma, HG; Nieweg, HO; Snijder, JA; Weenink-de Vries, J | 1 |
| Lyberg, T; Prydz, H | 1 |
| Edwards, RL; Rickles, FR | 1 |
| Ashkinazi, IIa | 1 |
| Fredrich, M; Morser, J; Witt, W; Wydro, R; Zierz, R | 1 |
| Aït-Chek, L; Bernat, A; Dumas, A; Herbert, JM; Savi, P | 1 |
| Alexander, M; Amirkhosravi, A; Biggerstaff, J; Francis, DA; Francis, JL; May, K; Warnes, G | 1 |
| Ahlstrom, CR; Gubler, DB; Liu, L; Parker, CJ; Rodgers, GM; Zhou, JF | 1 |
| Hanson, SR; Harker, LA; Kelly, AB; Wilcox, JN | 1 |
| Foss, KB; Joø, GB; Kierulf, P; Okkenhaug, C; Osnes, LT; Ovstebø, R; Westvik, AB | 1 |
| Badimon, J; Chesebro, JH; Fallon, JT; Fuster, V | 1 |
| Ezban, M; Hedner, U; Hoffman, M; Kjalke, M; Monroe, DM; Oliver, JA; Roberts, HR | 1 |
| Handa, M; Ikeda, Y; Kawai, Y; Matsumoto, Y; Murata, M; Nakamura, S; Sakai, K; Watanabe, K | 1 |
| Buchmann, M; Hamers, MJ; Sakariassen, KS; Stormorken, H | 1 |
| Barret, A; Boneu, B; Bossavy, JP; Cadroy, Y; Sagnard, L; Sakariassen, K; Thalamas, C | 1 |
| Boneu, B; Bossavy, JP; Cadroy, Y; Sakariassen, KS; Thalamas, C | 1 |
| Dzirlo, L; Eichler, HG; Hollenstein, U; Jilma, B; Kapiotis, S; Pernerstorfer, T; Speiser, W; Stohlawetz, P | 1 |
| Exner, M; Gmeiner, BM; Held, I; Hermann, M; Hofbauer, R; Kapiotis, S; Seelos, C; Speiser, W | 1 |
| Battaglia, C; Botticella, F; Chiariello, M; Cirillo, P; Esposito, N; Golino, P; Piro, O; Ponticelli, P; Ragni, M; Ramunno, L; Scognamiglio, A | 1 |
| Haug, KB; Joø, GB; Kierulf, P; Osnes, LT; Ovstebø, R; Westvik, AB | 1 |
| Cercek, B; Chyu, KY; Dimayuga, P; Fishbein, MC; Kangavari, S; Matetzky, S; Shah, PK; Tani, S; Xu, H; Yano, J | 1 |
| Ariëns, RA; Bernies, M; Bossi, IM; Brambilla, GM; Donatelli, F; Fajadet, J; Gregorini, L; Marco, I; Marco, J; Mari, D; Romano, SM; Somalvico, F | 1 |
| Dwyer, JH; Kaul, S; Meisel, SR; Merz, CN; Molloy, MD; Paul-Labrador, M; Rude, RK; Shah, PK; Shechter, M | 1 |
| Butenas, S; Cawthern, KM; DiLorenzo, ME; Lock, JB; Mann, KG; van't Veer, C | 1 |
| Degan, M; Gaino, S; Lechi, A; Meneguzzi, A; Minuz, P; Santonastaso, CL; Soldato, PD; Zuliani, V | 1 |
| Shah, PK | 1 |
| Levi, M; Moons, AH; Peters, RJ | 1 |
| FitzGerald, GA | 1 |
| del Soldato, P; Fiorucci, S; Lechi, A; Mencarelli, A; Meneguzzi, A; Minuz, P; Morelli, A | 1 |
| Bath, PM; Fox, S; Heptinstall, S; Judge, H; Lösche, W; May, J; Zhao, L | 1 |
| Christ, G; Huber, K; Kopp, CW; Maurer, G; Minar, E; Priglinger, U; Probst, P; Steiner, S | 1 |
| Bartell, S; Mahajan, S; Tibbles, HE; Uckun, FM; Vassilev, A; Zheng, Y | 1 |
| Nicholson, NS; Parlow, JJ; Salyers, AK; South, MS; Suleymanov, OD; Szalony, JA; Wood, RS | 1 |
| Arnesen, H; Hole, T; Hurlen, M; Seljeflot, I | 1 |
| Blom, JD; Case, BL; LaChance, RM; Nicholson, NS; Panzer-Knodle, SG; Parlow, JJ; Salyers, AK; South, MS; Suleymanov, OD; Szalony, JA; Wood, RS | 1 |
| Arnesen, H; Hurlen, M; Seljeflot, I | 1 |
| Blann, AD; Lim, HS; Lip, GY | 1 |
| Antman, EM; Mackman, N; McCabe, CH; Morrow, DA; Murphy, SA; Wong, HC | 1 |
| Altman, R; Gonzalez, C; Santoro, S; Scazziota, A | 1 |
| Bagga, S; Comerota, AJ; Gaughan, J; Jalagadugula, G; Rao, AK; Vaidyula, VR; Wilhite, DB | 1 |
| Cooper, AJ; Dusse, LM; Lwaleed, BA | 1 |
| Brown, J; Gammie, J; Griffith, BP; Gu, J; Jeudy, J; Nie, L; Pierson, RN; Poston, RS; Romar, L; White, C | 1 |
| Bednar, F; Jares, M; Mocikova, H; Osmancik, P; Straka, Z; Vanek, T; Widimsky, P | 1 |
| Ajzenberg, N; Feldman, L; Guillin, MC; Huisse, MG; Steg, PG | 1 |
| Bett, N; Juneja, M; Ray, MJ; Walters, DL | 1 |
| Brummel-Ziedins, K; Mann, KG; Siudak, Z; Tracz, W; Undas, A | 1 |
| Bareiss, P; Kessler, L; Morel, O; Ohlmann, P | 1 |
| Gartner, V; Hron, G; Kollars, M; Kyrle, PA; Lubsczyk, B; Weltermann, A | 1 |
| Bis, J; Pecka, M; Sevcik, R; Sevcikova, H; Vojacek, J | 1 |
| Christersson, C; Oldgren, J; Siegbahn, A; Wallentin, L | 1 |
| Bhatia, S; Medhi, B; Parmar, VS; Prasad, AK; Priya, N; Raj, HG; Singh, P | 1 |
| Hosokawa, K; Koide, T; Maruyama, I; Miura, N; Ohnishi, T; Sameshima, H; Tanaka, KA | 1 |
| Amadio, P; Barbieri, SS; Cavalca, V; Porro, B; Sandrini, L; Squellerio, I; Tarantino, E; Tremoli, E; Turnu, L | 1 |
| Bi, Y; Kou, J; Ma, R; Shi, J; Zhou, J | 1 |
| Angiolillo, DJ; Bass, TA; Been, L; Franchi, F; Galli, M; Geisler, T; Jaoude, PA; Jennings, LK; Jia, S; Lee, CH; Maaliki, N; Pineda, AM; Rivas, A; Rollini, F; Soffer, D; Suryadevara, S; Zenni, MM; Zhou, X | 1 |
6 review(s) available for aspirin and thromboplastin
| Article | Year |
|---|---|
Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway.
Topics: Amino Acid Sequence; Aspirin; Drug Resistance; Factor VIIa; Fibrinolytic Agents; Humans; Molecular Sequence Data; Recombinant Proteins; Risk Factors; Thromboplastin | 1996 |
Plaque rupture, thrombosis, and therapeutic implications.
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Coronary Thrombosis; Disease Progression; Drug Therapy, Combination; Endothelium, Vascular; Fibrinolytic Agents; Humans; Lipids; Models, Biological; Platelet Aggregation Inhibitors; Rupture, Spontaneous; Thromboembolism; Thromboplastin; Warfarin | 1996 |
Tissue factor and coronary artery disease.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Anticoagulants; Arginine; Aspirin; Coronary Artery Disease; Coronary Thrombosis; Cyclosporine; Endothelium, Vascular; Factor VIIa; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Hypolipidemic Agents; Leukocytes, Mononuclear; Muscle, Smooth, Vascular; Recombinant Proteins; Thrombin; Thromboplastin | 2002 |
Bioactive lipids and atherothrombosis.
Topics: Animals; Arachidonic Acids; Arteriosclerosis; Aspirin; Cyclooxygenase Inhibitors; Humans; Thromboplastin; Thrombosis | 2001 |
Tissue factor and nitric oxide: a controversial relationship!
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nitrates; Nitric Oxide; Pravastatin; Thromboplastin; Up-Regulation | 2007 |
Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis.
Topics: Acute Coronary Syndrome; Apoptosis; Aspirin; Blood Platelets; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Glycoproteins; Humans; Models, Biological; Piperazines; Platelet Activation; Prasugrel Hydrochloride; Receptors, Purinergic P2Y12; Thiophenes; Thromboplastin; Thrombosis; Ticlopidine | 2010 |
17 trial(s) available for aspirin and thromboplastin
| Article | Year |
|---|---|
"Car. factor" deficiency revisited.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aspirin; Black People; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Blood Protein Electrophoresis; Child; Child, Preschool; Clinical Trials as Topic; Collagen; Female; Humans; Male; Norepinephrine; Platelet Adhesiveness; Platelet Aggregation; Thrombin; Thromboplastin; White People | 1975 |
The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay.
Topics: Adult; Aged; Aged, 80 and over; Antigens; Aspirin; Blood Platelets; Collagen; Female; Flow Cytometry; Humans; Lipopolysaccharides; Male; Middle Aged; Monocytes; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Reproducibility of Results; Thromboplastin; Time Factors | 1996 |
A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans.
Topics: Adult; Arteries; Aspirin; Blood; Blood Platelets; Collagen; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Glass; Humans; Male; Models, Biological; Platelet Aggregation Inhibitors; Thromboplastin; Thrombosis; Ticlopidine | 1998 |
Antithrombotic efficacy of the vitamin K antagonist fluindione in a human Ex vivo model of arterial thrombosis : effect of anticoagulation level and combination therapy with aspirin.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Collagen; Drug Synergism; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Male; Phenindione; Thromboplastin; Thrombosis; Vitamin K | 1999 |
Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Antigens; Antithrombin III; Aspirin; Blood Coagulation; Dimerization; Double-Blind Method; Factor VII; Factor VIIa; Fibrin; Fibrinogen; Fibrinolytic Agents; Humans; Leukocyte Count; Lipopolysaccharides; Monocytes; Neutrophils; NF-kappa B; Peptide Fragments; Platelet Count; Protein C; Protein Precursors; Prothrombin; Solubility; Thromboplastin | 1999 |
Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris.
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antithrombin III; Aspirin; Atherectomy, Coronary; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Peptide Hydrolases; Platelet Aggregation Inhibitors; Premedication; Stents; Thromboplastin; Ticlopidine; Time Factors | 2000 |
Beneficial antithrombotic effects of the association of pharmacological oral magnesium therapy with aspirin in coronary heart disease patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Aspirin; Cell Adhesion; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Disease; Cross-Over Studies; Double-Blind Method; Electrolytes; Female; Fibrinolytic Agents; Flow Cytometry; Humans; Lipids; Magnesium; Magnesium Oxide; Male; Middle Aged; Monocytes; P-Selectin; Placebos; Platelet Aggregation; Prospective Studies; Thromboplastin; Thrombosis | 2000 |
Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
Topics: Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Angiography; Coronary Stenosis; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Factor Xa; Female; Follow-Up Studies; Hemorrhage; Heparin; Humans; Lipoproteins; Male; Middle Aged; Statistics as Topic; Stents; Thromboplastin; Thrombosis; Ticlopidine; Time Factors; Warfarin | 2003 |
Soluble tissue factor as predictor of future events in patients with acute myocardial infarction.
Topics: Adult; Aged; Aspirin; Biomarkers; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Regression Analysis; Thromboplastin; Warfarin | 2003 |
Increased levels of soluble tissue factor during long-term treatment with warfarin in patients after an acute myocardial infarction.
Topics: Adult; Aged; Aspirin; Biomarkers; Blood Coagulation Factors; Drug Therapy, Combination; Female; Hemostasis; Humans; International Normalized Ratio; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Solubility; Thromboplastin; Time Factors; Warfarin | 2004 |
Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trial.
Topics: Adult; Aged; Antibodies, Monoclonal; Aspirin; Blood Coagulation; Cohort Studies; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Half-Life; Hemorrhage; Humans; Injections, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombin; Thromboplastin | 2005 |
Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Antithrombin III; Aspirin; Blood Platelets; C-Reactive Protein; CD40 Ligand; Cell Membrane; Cilostazol; Clopidogrel; Down-Regulation; Drug Therapy, Combination; Factor VIIa; Humans; Middle Aged; P-Selectin; Peptide Fragments; Peptide Hydrolases; Peripheral Vascular Diseases; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Prothrombin; Tetrazoles; Thromboplastin; Ticlopidine | 2006 |
Perioperative management of aspirin resistance after off-pump coronary artery bypass grafting: possible role for aprotinin.
Topics: Aprotinin; Aspirin; Blood Coagulation; Cohort Studies; Coronary Artery Bypass, Off-Pump; Drug Resistance; Fibrinolytic Agents; Follow-Up Studies; Graft Survival; Hemostatics; Humans; Perioperative Care; Platelet Activation; Thromboplastin | 2008 |
Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET).
Topics: Aged; Aspirin; Confidence Intervals; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Graft Rejection; Graft Survival; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Count; Postoperative Care; Preoperative Care; Probability; Prognosis; Prospective Studies; Risk Assessment; Survival Analysis; Thromboplastin; Treatment Outcome | 2008 |
A comparison of anticoagulation with bivalirudin and provisional GPIIb/IIIa inhibition with unfractionated heparin and mandatory GPIIb/IIIa inhibition during percutaneous coronary intervention in relation to platelet activation and the inhibition of coagu
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biomarkers; Blood Coagulation; CD40 Ligand; Clopidogrel; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Hirudins; Humans; Lipoproteins; Male; Membrane Glycoproteins; Middle Aged; Monocytes; Peptide Fragments; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prothrombin; Recombinant Proteins; Thromboplastin; Thrombosis; Ticlopidine; Treatment Outcome | 2009 |
Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans.
Topics: Adult; Aspirin; beta-Thromboglobulin; Biomarkers; Blood Coagulation; Cell-Derived Microparticles; Cross-Over Studies; Double-Blind Method; Flow Cytometry; Humans; Immunoassay; Male; Peptide Fragments; Phosphatidylserines; Platelet Activation; Prospective Studies; Prothrombin; Thromboplastin | 2010 |
Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Aspirin; Azetidines; Benzylamines; Biomarkers; Blood Platelets; C-Reactive Protein; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Inflammation; Interleukin-10; Interleukin-18; Male; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Activation; Risk Factors; Thromboplastin; Time Factors; Treatment Outcome | 2011 |
53 other study(ies) available for aspirin and thromboplastin
| Article | Year |
|---|---|
[Informative value of control methods for postoperative supervision of medication with aspirin and heparin (author's transl)].
Topics: Aged; Antithrombins; Aspirin; Blood Coagulation Tests; Collagen; Female; Heparin; Humans; Lysine; Male; Middle Aged; Platelet Aggregation; Postoperative Care; Postoperative Complications; Preoperative Care; Thrombelastography; Thrombin; Thromboplastin; Thrombosis | 1977 |
Initial tumor cell arrest in animals of defined coagulative status.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Carcinoma; Heparin; Lymphoma, Non-Hodgkin; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Neoplastic Cells, Circulating; Thromboplastin; Warfarin | 1978 |
Hemostatic effects of uniform, low-dose subcutaneous heparin in surgical patients.
Topics: Adult; Aged; Aspirin; Blood Coagulation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemostasis, Surgical; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Postoperative Complications; Thromboplastin | 1978 |
Some interactions of blood with tubular biomaterials.
Topics: Animals; Aspirin; Biocompatible Materials; Blood; Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Proteins; Dogs; Female; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Male; Polyethylenes; Polyvinyl Chloride; Polyvinyls; Prothrombin Time; Silicone Elastomers; Surface Properties; Thrombin; Thromboplastin; Warfarin | 1975 |
Increased lipopolysaccharide-induced tissue factor activity and tumour necrosis factor production in monocytes after intake of aspirin: possible role of prostaglandin E2.
Topics: Adult; Aspirin; Dinoprostone; Female; Humans; Lipopolysaccharides; Male; Middle Aged; Monocytes; Thromboplastin; Thromboxane B2; Tumor Necrosis Factor-alpha | 1992 |
The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients.
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Enzyme-Linked Immunosorbent Assay; Female; Fetal Death; Humans; Lupus Coagulation Inhibitor; Male; Middle Aged; Pregnancy; Pregnancy Complications; Thromboplastin; Thrombosis | 1991 |
Choline inhibition of prothrombin activation.
Topics: Aspirin; Calcium; Choline; Dipeptides; Enzyme Activation; Factor Xa Inhibitors; Humans; Kinetics; Liposomes; Microcomputers; Phospholipids; Prothrombin; Spectrophotometry; Thromboplastin | 1991 |
Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Coagulation Factors; Blood Platelets; Cyclooxygenase Inhibitors; Endotoxins; Humans; Hydroxyeicosatetraenoic Acids; Leukocytes; Thromboplastin | 1986 |
Effect of lipopolysaccharides on cultured human endothelial cells. Relationship between tissue factor activity and prostacyclin release.
Topics: 6-Ketoprostaglandin F1 alpha; Adenine; Arachidonic Acid; Arachidonic Acids; Aspirin; Cells, Cultured; Endothelium; Epoprostenol; Humans; L-Lactate Dehydrogenase; Lipopolysaccharides; Thromboplastin; Time Factors; Tritium | 1987 |
[Studies on anti-inflammatory agents. 18. Effect of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridine (Y-3642) on the release of histamine in vitro and in vivo].
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Benzyl Compounds; Depression, Chemical; Dextrans; Diphenhydramine; Flufenamic Acid; Histamine Release; In Vitro Techniques; Mast Cells; Phenylbutazone; Polymyxins; Pyridines; Rats; Thiophenes; Thromboplastin | 1971 |
Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin.
Topics: Aminocaproates; Animals; Aprotinin; Aspirin; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Cyclohexanecarboxylic Acids; Disseminated Intravascular Coagulation; Enzyme Activation; Enzyme Inhibitors; Fibrin; Fibrinogen; Fibrinolysin; Heparin; Heparin Antagonists; Kidney; Lung; Methylamines; Plasminogen; Platelet Aggregation; Protease Inhibitors; Thrombin; Thromboplastin | 1974 |
The function of the platelet surface in coagulation. Some preliminary observations, with two new tests of platelet function.
Topics: Animals; Aspirin; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Factor X; Humans; Phenylbutazone; Snakes; Surface Properties; Thrombin; Thromboplastin; Time Factors; Venoms | 1974 |
Platelet aggregation by Thrombofax.
Topics: Adenosine Diphosphate; Afibrinogenemia; Anti-Inflammatory Agents; Aspirin; Blood Platelets; Citrates; Densitometry; Dose-Response Relationship, Drug; Drug Stability; Drug Storage; Epinephrine; Factor V Deficiency; Factor VII Deficiency; Factor XIII Deficiency; Fatty Acids, Nonesterified; Heparin; Humans; Platelet Adhesiveness; Serum Albumin; Temperature; Thromboplastin; Time Factors | 1972 |
The possible role of platelets as trigger in intravascular coagulation associated with acute hyperparathyroidism.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Cell Count; Blood Platelets; Calcium; Carcinoma 256, Walker; Collagen; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hypercalcemia; Hyperparathyroidism; Neoplasm Transplantation; Parathyroid Hormone; Platelet Adhesiveness; Radiation Effects; Rats; Sarcoma, Yoshida; Thromboplastin; Time Factors; Transplantation, Homologous | 1972 |
The platelet of the newborn infant. 5-Hydroxytryptamine uptake and release.
Topics: Adenine Nucleotides; Amines; Aspirin; Blood Platelet Disorders; Blood Platelets; Carbon Isotopes; Cell Membrane; Cerebral Hemorrhage; Collagen; Contusions; Ecchymosis; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intestinal Secretions; Platelet Adhesiveness; Serotonin; Thromboplastin; Vitamin K Deficiency Bleeding | 1973 |
Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasis.
Topics: Aspirin; Blood Cell Count; Blood Platelet Disorders; Blood Platelets; Factor XII; Female; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, Diseases; Maternal-Fetal Exchange; Pregnancy; Prothrombin Time; Thromboplastin | 1970 |
The effect of oxyphenbutazone on partial thromboplastin time and lack of effect on Hageman factor in guinea pigs.
Topics: Animals; Aspirin; Blood Coagulation Tests; Capillary Permeability; Factor XII; Guinea Pigs; Inflammation; Oxyphenbutazone; Thromboplastin | 1971 |
Platelet factor 3 (PF 3) and platelet factor 4 (PF 4) as a guide to platelet membrane structure.
Topics: Aspirin; Blood Coagulation Factors; Blood Platelets; Cell Membrane; Heparin Antagonists; Osmosis; Thromboplastin | 1971 |
Dissociation between platelet factor 3 availability and platelet aggregation.
Topics: Absorption; Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Collagen; Glycolysis; Humans; Indomethacin; Oxidative Phosphorylation; Platelet Adhesiveness; Purpura, Thrombocytopenic; Spectrum Analysis; Thromboplastin; Time Factors | 1971 |
A familial defect in platelet function associated with impaired release of adenosine diphosphate.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Adult; Aspirin; Blood Coagulation; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Cell Aggregation; Child; Clot Retraction; Connective Tissue; Epinephrine; Female; Genes, Dominant; Humans; In Vitro Techniques; Kaolin; Lipids; Male; Middle Aged; Pedigree; Platelet Adhesiveness; Temperature; Thromboplastin | 1969 |
The occurrence of antibodies against acetylsalicylic acid and related compounds in thrombocytopenic purpura.
Topics: Animals; Antibodies; Aspirin; Blood Coagulation Tests; Drug Hypersensitivity; Humans; Purpura, Thrombocytopenic; Rabbits; Thromboplastin | 1969 |
Effect of some drugs on thromboplastin (factor III) activity of human monocytes in vitro.
Topics: Aspirin; Cyclic AMP; Dexamethasone; Glucuronidase; Humans; In Vitro Techniques; Indomethacin; L-Lactate Dehydrogenase; Monocytes; Muramidase; Promethazine; Thromboplastin | 1980 |
Activation of blood coagulation in cancer: Trousseau's syndrome revisited.
Topics: Antibodies; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Cell Adhesion; Cell Communication; Cyclooxygenase Inhibitors; Disseminated Intravascular Coagulation; Epoprostenol; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Indomethacin; Monocytes; Neoplasm Transplantation; Neoplasms; Syndrome; Thrombocytopenia; Thrombocytosis; Thromboembolism; Thromboplastin | 1983 |
[Acetylsalicylic acid and the procoagulant activity of erythrocytes].
Topics: Adult; Anticoagulants; Arteriosclerosis; Aspirin; Blood Coagulation; Cells, Cultured; Erythrocytes; Female; Humans; In Vitro Techniques; Male; Middle Aged; Thrombin; Thromboplastin | 1981 |
A new animal model of venous thrombosis in rats with low flow conditions in the venous blood stream.
Topics: Animals; Anticoagulants; Aspirin; Blood Flow Velocity; Constriction; Disease Models, Animal; Epoprostenol; Heparin; Male; Platelet Aggregation Inhibitors; Prostaglandins, Synthetic; Rats; Rats, Wistar; Recombinant Proteins; Thrombomodulin; Thrombophlebitis; Thromboplastin; Vena Cava, Inferior | 1994 |
Effect of aspirin and clopidogrel on platelet-dependent tissue factor expression in endothelial cells.
Topics: Adenosine Diphosphate; Animals; Aorta; Aspirin; Blood Platelets; Cattle; Clopidogrel; Endothelium, Vascular; Female; Ligation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Thionucleotides; Thrombin; Thromboplastin; Thrombosis; Ticlopidine; Vena Cava, Inferior | 1994 |
Procoagulant albumin increases vascular endothelial cell prostacyclin secretion.
Topics: Aspirin; Binding Sites; Blood Coagulation Factors; Blood Platelets; Endothelium, Vascular; Epoprostenol; Humans; Nitric Oxide; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Serum Albumin; Suramin; Thromboplastin; von Willebrand Factor | 1995 |
Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-alpha) in human monocytes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biological Transport; Cells, Cultured; Humans; Monocytes; NF-kappa B; Sodium Salicylate; Thromboplastin; Tumor Necrosis Factor-alpha | 1996 |
The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.
Topics: Adult; Amino Acid Chloromethyl Ketones; Aspirin; Binding Sites; Binding, Competitive; Blood Coagulation; Blood Platelets; Calcium; Cells, Cultured; Cyclooxygenase Inhibitors; Drug Administration Schedule; Drug Interactions; Factor VII; Factor VIIa; Fibrinolytic Agents; Humans; Kinetics; Lipopolysaccharides; Monocytes; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Binding; Recombinant Proteins; Serine Proteinase Inhibitors; Thrombin; Thromboplastin | 1997 |
Fluid shear stress attenuates tumor necrosis factor-alpha-induced tissue factor expression in cultured human endothelial cells.
Topics: Aspirin; Cells, Cultured; Endothelium, Vascular; Factor VIIa; Factor X; Hemorheology; Humans; NG-Nitroarginine Methyl Ester; RNA, Messenger; Stress, Mechanical; Thromboplastin; Tumor Necrosis Factor-alpha | 1998 |
Iohexol, platelet activation and thrombosis. II. Iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin.
Topics: Anticoagulants; Aspirin; beta-Thromboglobulin; Blood Platelets; Collagen; Contrast Media; Drug Interactions; Heparin; Humans; In Vitro Techniques; Iohexol; Ioxaglic Acid; Male; Platelet Activation; Thromboplastin; Thrombosis; Triiodobenzoic Acids | 1998 |
The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein.
Topics: Arteriosclerosis; Aspirin; Cells, Cultured; Diabetic Angiopathies; Endothelium, Vascular; Gentisates; Glucose; Humans; Hydroxybenzoates; Iron Chelating Agents; Lipoproteins, LDL; Male; Oxidation-Reduction; Prodrugs; Reactive Oxygen Species; Salicylic Acid; Thromboplastin | 2000 |
Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury.
Topics: Animals; Antibodies; Aspirin; Blood Coagulation; Blood Flow Velocity; Carotid Artery Injuries; Carotid Stenosis; Disease Models, Animal; Endothelium, Vascular; Female; Male; Platelet Aggregation Inhibitors; Rabbits; Thromboplastin; Thrombosis | 2000 |
Aspirin potentiates LPS-induced fibrin formation (FPA) and TNF-alpha-synthesis in whole blood.
Topics: Aspirin; Blood Cells; Dinoprostone; Dose-Response Relationship, Drug; Fibrin; Fibrinopeptide A; Humans; Interleukin-10; Lipopolysaccharides; Monocytes; Peptide Fragments; Prothrombin; RNA, Messenger; Thromboplastin; Tumor Necrosis Factor-alpha | 2000 |
Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity.
Topics: Aged; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Aspirin; Carotid Arteries; Carotid Artery Diseases; Female; Humans; Male; Mice; Mice, Knockout; Middle Aged; Smoking; Thromboplastin; Thrombosis | 2000 |
Antiplatelet agents in tissue factor-induced blood coagulation.
Topics: Abciximab; Adult; Alprostadil; Animals; Antibodies, Monoclonal; Antithrombin III; Aspirin; Blood Coagulation; Dipyridamole; Eptifibatide; Fibrinopeptide A; Humans; Immunoglobulin Fab Fragments; Mice; Osteonectin; Partial Thromboplastin Time; Peptide Hydrolases; Peptides; Plant Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proteins; Prothrombin Time; Receptors, Thrombin; Thromboplastin | 2001 |
NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes.
Topics: Aspirin; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrinolytic Agents; Guanylate Cyclase; Humans; Interleukin-6; Lipopolysaccharides; Monocytes; Nitric Oxide; Oxadiazoles; Quinoxalines; Thromboplastin; Thromboxane B2; Tumor Necrosis Factor-alpha | 2001 |
Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis?
Topics: Animals; Anticoagulants; Arteriosclerosis; Aspirin; Fibrinolytic Agents; Heparin; Humans; Lipoproteins; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Thromboplastin; Thrombosis | 2002 |
NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cyclooxygenase 2; Cysteine Proteinase Inhibitors; Drug Administration Schedule; Flow Cytometry; Gastric Mucosa; Interleukin-1; Isoenzymes; Isosorbide Dinitrate; Male; Monocytes; Nitric Oxide; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Thromboxane B2; Tumor Necrosis Factor-alpha | 2002 |
The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions.
Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD11b Antigen; Dipyridamole; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Leukocytes; Monocytes; Neutrophils; Oligopeptides; Peptides, Cyclic; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin | 2003 |
The anti-leukemic Bruton's tyrosine kinase inhibitor alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13) prevents fatal thromboembolism.
Topics: Adenosine Diphosphate; Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Aspirin; Bleeding Time; Catalytic Domain; Collagen; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fibrinolytic Agents; Humans; Janus Kinase 3; Male; Mice; Mice, Inbred ICR; Nitriles; Peptide Fragments; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Pulmonary Embolism; Quinazolines; Receptors, Collagen; Signal Transduction; Thrombin; Thromboembolism; Thromboplastin | 2003 |
Assessment of bleeding propensity in non-human primates by combination of selective tissue factor/VIIa inhibition and aspirin compared to warfarin and aspirin treatment.
Topics: Aminobenzoates; Animals; Anticoagulants; Aspirin; Bleeding Time; Dose-Response Relationship, Drug; Drug Combinations; Factor VIIa; Hemorrhage; Macaca fascicularis; Male; Platelet Aggregation Inhibitors; Prothrombin Time; Pyrazines; Thromboplastin; Warfarin; Whole Blood Coagulation Time | 2004 |
Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time.
Topics: Animals; Aspirin; Bleeding Time; Body Weight; Disease Models, Animal; Factor VIIa; Macaca fascicularis; Male; Platelet Aggregation Inhibitors; Thromboplastin; Thrombosis | 2003 |
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
Topics: Aged; Aspirin; Biomarkers; Blood Coagulation; Cardiovascular Diseases; CD40 Ligand; Cohort Studies; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypoglycemic Agents; Inflammation; Interleukin-6; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Risk Factors; Risk Management; Thromboplastin | 2004 |
Abciximab does not inhibit the increase of thrombin generation produced in platelet-rich plasma in vitro by sodium arachidonate or tissue factor.
Topics: Abciximab; Adult; Aged; Antibodies, Monoclonal; Arachidonic Acid; Aspirin; Blood Platelets; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Reference Values; Thrombin; Thromboplastin | 2005 |
Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biomarkers; Case-Control Studies; Cell-Derived Microparticles; Coronary Angiography; Coronary Circulation; Drug Administration Schedule; Drug Therapy, Combination; Emergency Treatment; Female; Fibrinolysin; Fibrinolytic Agents; Hemostasis; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Thrombin; Thrombolytic Therapy; Thromboplastin; Time Factors; Tissue Plasminogen Activator; Treatment Failure | 2009 |
Prothrombinase formation at the site of microvascular injury and aspirin resistance: the effect of simvastatin.
Topics: Arachidonic Acid; Aspirin; Bleeding Time; Drug Combinations; Drug Resistance; Factor X; Fasting; Humans; Male; Middle Aged; Outpatients; Platelet Aggregation; Simvastatin; Thromboplastin; Time Factors; Wounds and Injuries | 2010 |
Increased platelet residual activity in patients treated with acetosalicylic acid is associated with increased tissue factor and decreased tissue factor pathway inhibitor plasma levels.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Female; Humans; Lipoproteins; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Thromboplastin | 2011 |
Characterization of a unique dihydropyrimidinone, ethyl 4-(4'-heptanoyloxyphenyl)-6-methyl-3,4-dihydropyrimidin-2-one-5-carboxylate, as an effective antithrombotic agent in a rat experimental model.
Topics: Adenosine Diphosphate; Animals; Aorta; Aspirin; Blood Platelets; Collagen; Cyclic GMP; Drug Synergism; Inflammation Mediators; Inhibitory Concentration 50; Lipopolysaccharides; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Platelet Aggregation Inhibitors; Pyrimidinones; Rats; Rats, Sprague-Dawley; Thrombin; Thromboplastin; Thrombosis | 2011 |
Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model.
Topics: Adenosine Triphosphate; Adult; Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Blood Platelets; Dabigatran; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Female; Fibrin; Humans; Lab-On-A-Chip Devices; Male; Microscopy, Confocal; Morpholines; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rivaroxaban; Thiophenes; Thrombin; Thromboplastin; Thrombosis | 2014 |
Role of thromboxane-dependent platelet activation in venous thrombosis: Aspirin effects in mouse model.
Topics: Animals; Aspirin; Blood Platelets; Cell-Derived Microparticles; Disease Models, Animal; Male; Mice; Neutrophils; Platelet Activation; Platelet Aggregation Inhibitors; Thromboplastin; Thromboxanes; Vena Cava, Inferior; Venous Thrombosis | 2016 |
Enhanced procoagulant activity of platelets after chemotherapy in non-small cell lung cancer.
Topics: Aged; Antigens, Surface; Aspirin; Bleeding Time; Blood Coagulation; Blood Platelets; Carcinoma, Non-Small-Cell Lung; Cell-Derived Microparticles; Female; Humans; Lung Neoplasms; Male; Middle Aged; Milk Proteins; Phosphatidylserines; Platelet Aggregation Inhibitors; Thrombin; Thromboplastin; Thrombosis; Up-Regulation | 2017 |
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy.
Topics: Aspirin; Clopidogrel; Cyclooxygenase 1; Fibrinolytic Agents; Humans; Peptides; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Thrombin; Rivaroxaban; Thrombin; Thromboplastin; Ticagrelor | 2022 |